Fundraising Fox

UniSeed Pty Ltd.

Venture capitaloperating company · company profile

Brisbane · Pre-Seed–Series A · 12 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Uniseed is a commercialisation fund that backs researchers and early-stage technologies coming out of its partner research organisations, aiming to turn academic ideas into commercial products and services. It provides seed capital to progress and de-risk innovations both technically and commercially, alongside mentoring, access to a network of industry experts and co-investors, and support with commercialisation strategy and intellectual property. The fund invests across a broad range of technology sectors and prioritises innovations that solve market problems and deliver positive community impact. It has made investments in around 70 start-ups and has achieved twelve exits to date.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Series A
Check
$165K – $330K
HQ
Brisbane, Queensland, AU
Leads rounds
Follows
Instruments
Equity
Founded
2000
AUM
$39.6M
Tracked investments
22

Team · 12 people

from the firm's website & curated & public directories

What they invest in

from 18 of 22 portfolio companies

Biotech ×9Healthtech ×9Medical Devices ×8Hardware ×6Deep Tech ×3Digital Health ×3IoT ×3Advanced Manufacturing ×1

HQs:Australia×9

Investments · 22 tracked

founders shown can be your intro path
Aravaxaravax.com.auin

Aravax is a clinical-stage biotechnology company developing next-generation immunotherapies to treat food allergies.

BiotechHealthtechMedical DevicesMelbourne, AU

Sara Prickett(Co-founder)

Co-investorsNovartis Venture FundTenmileBreakthrough Victoria

Aurorasolartechaurorasolartech.comin

Aurora develops inline process measurement, visualization, and control systems for photovoltaic (PV) solar cell manufacturing.

Advanced ManufacturingCleantechHardware

BioScout Automated Agricultural Disease Detectionbioscout.com.auin𝕏

BioScout provides autonomous, solar-powered air sampling devices that detect and identify airborne fungal spores, combining live spore counts with weather data to give growers, agronomists, and agrochemical distributors disease-risk intelligence for fungicide spray timing.

AgTechAI & Machine LearningDeep TechHardwareIoT

Lewis Collins(CEO)

Co-investorsArtesianStoic VC

Cardihab Improving cardiovascular diseasecardihab.comin𝕏

Cardihab provides a digital cardiac rehabilitation platform that uses smartphone apps and web portals to enable clinicians to deliver remote and flexible rehabilitation services to patients with heart disease.

Digital HealthHealthtechMedical DevicesQueensland, AU

Co-investorsStoic VC

CERTA Therapeuticscertatherapeutics.comin

Certa Therapeutics develops targeted therapeutics to treat fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy, and focal segmental glomerulosclerosis.

BiotechHealthtechMedical Devices

Co-investorsStoic VC

Currusbiocurrusbio.comin

Currus Biologics develops CAR T-cell immunotherapy for solid tumours using its proprietary BEAT platform, which recreates the immune-supportive conditions that CAR T-cells rely on to overcome barriers such as poor persistence, T-cell exhaustion, and limited tumour infiltration.

BiotechHealthtech

diraqdiraq.comin𝕏

Diraq develops quantum computers based on modified silicon transistors, aiming for utility-scale quantum processing units the size of a single data-center rack.

Deep TechHardwareQuantum Computing

Co-investorsimec.xpandQuantonationIn-Q-Tel

Ena Respiratoryenarespiratory.comin

ENA Respiratory develops and brings respiratory treatments to market across the US and other regions.

BiotechHealthtechMedical DevicesMelbourne, AU

Christophe Demaison(CEO)

Co-investorsBrandon BioCatalystStoic VC

Exonate - companyexonate.comin𝕏

Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.

BiotechDigital HealthHealthtechMedical Devices

Olav Hellebø(Chief Executive Officer)

Co-investorsO2h VenturesWellcome TrustWren CapitalCambridge Angels groupEMV CapitalMartlet Capital+1 more

Ferronovaferronova.com.auin

Ferronova develops magnetic iron-oxide nanoparticle tracers (FerroTrace) and related imaging and therapy technologies to detect and map lymph nodes and tumours in early-stage cancers, supporting surgeons, oncologists and pathologists in staging and treating cancers such as oral, colorectal, esophageal, prostate and pancreatic.

BiotechHealthtechMedical Devices

Benjamin Thierry(Scientific Advisor/Founder)Stewart Bartlett(CEO)Anil Shetty(CMO)

Co-investorsArtesianSouth Australian Venture Capital FundBooster Innovation FundMatūStoic VC

Hatchtech.Comhatchtech.com.au
Kinoxis Therapeuticskinoxistherapeutics.comin𝕏

Kinoxis Therapeutics develops novel therapeutics targeting inflammatory signaling pathways in the nervous system to address unmet needs in CNS disorders, with initial focus on treatments for agitation and pain.

BiotechDigital HealthHealthtechMedical DevicesMelbourne, AU

Hugh Alsop(Chief Executive Officer, Co-Founder)Michael Bowen(Chief Scientific Officer, Co-Founder)

Co-investorsStoic VC

Morse Micromorsemicro.comin𝕏

Morse Micro designs Wi-Fi HaLow (IEEE 802.11ah) system-on-chip semiconductors that provide long-range, low-power sub-1 GHz wireless connectivity for IoT devices such as security cameras, dongles, and access points.

HardwareIoTSemiconductorsSydney, AU

Andrew Terry(Co-founder & CTO)inMichael De Nil(Co-founder & CEO)inJoe Bedewi(Chief Financial Officer)in

Co-investorsMain Sequence VenturesBlackbird VenturesRight Click CapitalSpringCapital InvestmentStoic VCVirescent Ventures+1 more

Naiapharmanaiapharma.com
Otifexotifex.com
Perkii.Comperkii.com.auin

PERKii makes probiotic drinks using a micro-shielding technology that protects live probiotics from stomach acid for targeted release in the gut, marketed for immune and gut health support.

ConsumerFoodTechWellness & Fitness

Progel.Comprogel.com.au
Q Seraq-sera.com

Q-Sera is a biotech company backed by Australian investors Uniseed and Brandon BioCatalyst, emerging from University of Queensland commercialisation efforts.

BiotechHealthtechMedical DevicesBrisbane, AU

Michael Grant(Chief Executive Officer)

Co-investorsBrandon BioCatalystStoic VC

Smartsparrowsmartsparrow.comin𝕏

Smart Sparrow provides a digital learning platform and design studio for creating learning experiences and assessments.

EdTechSaaS

Tinybrightthingstinybrightthings.comin𝕏

HaloMicroscopy develops laser-free, label-free optical imaging instruments that capture live cells, tissues, and materials in air or liquid without sample prep or fluorescent tags.

BiotechDeep TechHardware

Veriquantixveriquantix.com

VeriQuantix presents itself as a data security company focused on protecting enterprise data against breaches.

CybersecurityEnterprise Software

Co-investorsSilicon Catalyst

Wildlifedroneswildlifedrones.netin𝕏

Wildlife Drones offers a drone-based radio-telemetry system ("Dragonfly") that tracks up to 40 VHF-tagged animals simultaneously in real time across large or difficult terrain.

Climate TechHardwareIoT

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does UniSeed Pty Ltd. invest at?
UniSeed Pty Ltd. invests at the Pre-Seed, Seed, Series A stages.
What is UniSeed Pty Ltd.'s typical check size?
UniSeed Pty Ltd. typically writes checks of $165K – $330K.
What sectors does UniSeed Pty Ltd. focus on?
UniSeed Pty Ltd. focuses on Biotech, Deep Tech, Hardware, Healthtech, Medical Devices, New Materials, Sector Agnostic, Semiconductors.
Where is UniSeed Pty Ltd. located?
UniSeed Pty Ltd. is headquartered in Brisbane, AU.
Does UniSeed Pty Ltd. lead rounds?
UniSeed Pty Ltd. typically participates in rounds rather than leading them.

Similar investors

Featured in lists